BRIEF published on 10/31/2024 at 05:50, 21 days 5 hours ago China XLX Reports 80% Surge in Nine-Month Profit for 2024 Cost Reduction 2024 Financial Results China XLX Profits Urea Production Growth Efficiency Enhancement
PRESS RELEASE published on 10/31/2024 at 05:45, 21 days 5 hours ago China XLX Announces 2024 First Three Quarters Results China XLX's profit for the first nine months of 2024 surged by 80% YoY with notable efficiency enhancements and cost reductions. Revenue amounted to RMB 17.42 billion Revenue Increase Cost Reduction China XLX Efficiency Enhancement Profit Surge
BRIEF published on 08/25/2024 at 12:15, 2 months 26 days ago China XLX Announces 2024 Interim Results Financial Improvement Profit Growth 2024 Interim Results China XLX Fertiliser Sales
PRESS RELEASE published on 08/25/2024 at 12:10, 2 months 26 days ago China XLX Announces 2024 Interim Results China XLX Fertiliser Ltd. reports improved financial performance in 2024 interim results. Revenue slightly increased, profit surged, and efficiency enhancements led to profit growth Finance Efficiency Profit Growth China XLX Fertiliser 2024 Interim Results
BRIEF published on 04/26/2024 at 07:50, 6 months 25 days ago China XLX Fertiliser Reports Decline in Profits but Growth in Core Product Margins for Q1 2024 Financial Results Market Strategy China XLX Fertiliser Product Development Production Increase
PRESS RELEASE published on 04/26/2024 at 07:45, 6 months 25 days ago China XLX Announces 2024 1Q Results China XLX Fertiliser reports a decrease in income but stabilised gross profit margins for core products by promoting high-efficiency fertilisers. Highlights from the 2024 1Q results China XLX Fertiliser Income Decrease Gross Profit Margins Stabilization High-efficiency Fertilisers 2024 1Q Results
PRESS RELEASE published on 05/08/2023 at 05:30, 1 year 6 months ago China XLX Announces 2023 1Q Results
PRESS RELEASE published on 03/27/2023 at 06:05, 1 year 7 months ago China XLX Announces 2022 Annual Results
Published on 11/21/2024 at 10:03, 50 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 53 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 53 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 18 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 28 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 22 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 48 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 50 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 52 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 52 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 55 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 33 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 8 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 8 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
